This stock is well undervalued but until all the products are finished, it moves on news and then the day traders take charge until next news.. current book value app $ 4.50 ps and the latest financial reports show a great percentage decrease of expenses from the previous one.
If they keep getting good result with their clinical trials have not doubt that they will fall on some bigger pharmaceutical company's eyes.. !
News 
Market Data 
Discover 
